Collins was among the first members of Congress to endorse President Donald Trump's presidential campaign.
New York Gov. Andrew M. Cuomo, a Democrat, would set the date of a special election if he were to call one before November 2020. He easily won re-elections for his second and third terms in 2014 and 2016, but faced a stiffer challenge from McMurray in 2018, emerging victorious in a close contest. Voters elected Democrat Joe Morelle in both elections. On the Republican side, Erie County Comptroller Stefan Mychajliw, Iraq war veteran and Medal of Honor recipient David Bellavia, state senators Chris Jacobs and Robert Ortt and attorney Beth Parlato are rumored to have interest. While he originally said past year that he would not seek reelection following the indictment against him, he reversed course and eventually defeated Democrat challenger Nate McMurray - albeit by a much narrower margin than expected, 49.1 percent to McMurray's 48.8 percent.
Inside Elections with Nathan L. Gonzales has changed its race rating from Leans Republican to Solid Republican. A federal court hearing is scheduled for Collins Tuesday at 3 p.m.in Manhattan before Judge Vernon S. Broderick.
Collins, who was among the first members of Congress to support President Donald Trump's run for the White House, had been scheduled to go to trial next year on charges he illegally leaked confidential information about a biopharmaceutical company to his son, allowing Cameron Collins and another man to avoid almost $800,000 in stock losses. The two sold their shares in the company before the news was made public, allowing them to dodge almost $800,000 in losses.
Half of Collins' full-time staff has left the office since he was indicted in August 2018 on fraud charges.
Ukraine wants to stay out of United States domestic affairs
He also said that his administration would not publish the transcripts of the phone call he had with the USA president on July 25. Giuliani recently told The Washington Post that he possessed communications with State Department officials about his effort .
The charges stem from Collins' decision to pass on information about Innate Immunotherapeutics Ltd., a biotechnology company headquartered in Sydney, Australia. Chris Collins was one of its largest shareholders and sat on its board of directors.
Prosecutors allege Collins, 69, was at a picnic at the White House on June 22 previous year when Innate's chief executive sent a highly-confidential email to Collins confirming the company's key multiple sclerosis drug had failed a critical trial.
A spokesman for US Attorney Geoffrey Berman, whose office is prosecuting the case, declined to comment, as did Mauro Wolfe, a lawyer for Zarsky. "Makes no sense. How are these results even possible???" the indictment said.
Prosecutors allege Collins passed along secrets to his son in June 2017. By the time the news went public, Cameron Collins and Zarsky had dumped their shares, avoiding losses of $768,000, prosecutors say.